journal article·2018-07-25

Gold Nanoparticles Bearing a Tumor pH-Sensitive Cyclodextrin Cap

Mijin Koo, Kyung Taek Oh, Gwangjin Noh, Eun Seong Lee

ACS Applied Materials & Interfaces· Volume 10· Issue 29
Publisher page

Abstract

We report functional gold nanoparticles (AuNPs) with a pH-sensitive γ-cyclodextrin (CD) cap. These particles include two chargeable CD molecules on their surface. CD with dopamine and amine (NH2) groups (hereafter termed as dCD-NH2) was anchored to the gold surface and then electrostatically complexed with the CD with 2,3-dimethylmaleic acid (DMA) and chlorin e6 (Ce6) (hereafter termed as cCD-DMA), producing an ionic complex consisting of dCD-NH2 and cCD-DMA. Under the acidic environment (pH 6.8) existing in most solid tumors, the ionic complex was destabilized because of the decoupling of DMA, resulting in the release of cCD (without DMA) from the AuNPs, resulting in extensive tumoral uptake of AuNPs with dCD-NH2 (because of their electrostatic attraction to tumor cells). This event resulted in a significant increase in the efficiency of cellular AuNP uptake and light-driven (AuNP-mediated photothermal and Ce6-mediated photodynamic) ablation of acidic solid tumors, suggesting marked potential for tumor therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotechnology, The Catholic University of Korea, 43 Jibong-ro, Bucheon-si, Gyeonggi-do 14662, Republic of Korea

College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Republic of Korea

Funding

National Research Foundation of Korea

References (29)

Show source-provided references
1. 10.1002/adma.20160556310.1002/adma.201605563 ↗
2. 10.1021/cr400532z10.1021/cr400532z ↗
3. 10.1021/nn506411q10.1021/nn506411q ↗
4. 10.1039/c5tb00414d10.1039/c5tb00414d ↗
5. 10.1039/c6tb01894g10.1039/c6tb01894g ↗
6. 10.1002/adfm.20140309510.1002/adfm.201403095 ↗
7. 10.1002/adhm.20160145310.1002/adhm.201601453 ↗
8. 10.1016/j.ejmech.2017.06.03410.1016/j.ejmech.2017.06.034 ↗
9. 10.1016/j.biomaterials.2015.05.00610.1016/j.biomaterials.2015.05.006 ↗
10. 10.1039/c5nr01408e10.1039/c5nr01408e ↗
11. 10.1016/j.biomaterials.2018.03.04610.1016/j.biomaterials.2018.03.046 ↗
12. 10.1016/j.jconrel.2018.04.00510.1016/j.jconrel.2018.04.005 ↗
13. 10.1016/j.colsurfb.2014.04.01710.1016/j.colsurfb.2014.04.017 ↗
14. 10.1016/j.carbpol.2017.12.07810.1016/j.carbpol.2017.12.078 ↗
15. 10.1002/anie.20100603810.1002/anie.201006038 ↗
16. 10.1016/j.biomaterials.2011.11.02610.1016/j.biomaterials.2011.11.026 ↗
17. 10.1039/c0cc03590d10.1039/c0cc03590d ↗
18. 10.1016/j.jconrel.2008.05.00310.1016/j.jconrel.2008.05.003 ↗
19. 10.2967/jnumed.109.06898110.2967/jnumed.109.068981 ↗
20. 10.1002/jmri.1018110.1002/jmri.10181 ↗
21. 10.1002/anie.20090658410.1002/anie.200906584 ↗
22. 10.1021/nn102722z10.1021/nn102722z ↗
23. 10.1016/j.ijpharm.2014.05.02810.1016/j.ijpharm.2014.05.028 ↗
24. 10.1016/j.ijpharm.2014.05.02910.1016/j.ijpharm.2014.05.029 ↗
25. 10.7150/thno.2262110.7150/thno.22621 ↗
26. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
27. 10.1186/1556-276x-7-42310.1186/1556-276x-7-423 ↗
28. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
29. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗